AI-generated analysis. Always verify with the original filing.
Q32 Bio Inc. filed an 8-K on March 10, 2026, announcing its financial results for the quarter ended December 31, 2025, under Item 2.02, with details provided in Exhibit 99.1 press release.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On March 10, 2026, Q32 Bio Inc. announced its financial results for the quarter ended December 31, 2025 and provi
Financial Statements and Exhibits. 99.1 Press Release issued by Q32 Bio Inc. on March 10, 2026 104 Cover Page Interactive Data File (embedded within the Inline